Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4801–4850 of 18416
Mr. Nelson’s employment termination date is June 10, 2024 (the “Separation Date”) resigning from all positions including position as a non-employee Director on the Board of Directors, in lieu of an involuntary termination without cause.
The Company named Dean Rudy Chief Financial Officer (“CFO”), effective June 10, 2024.
Mr. Black will succeed J. Barton Kalsu, who tendered his resignation on June 6, 2024 in order to explore other professional opportunities outside of the Company.
On June 10, 2024, SolarWinds Corporation (the “Company”) announced that Lewis Black will join the Company on June 24, 2024, and has been appointed as the Company’s Executive Vice President and Chief Financial Officer, effective on or about August 15, 2024
On June 10, 2024, the Board of Directors (the "Board") of Sunnova Energy International, Inc. (the "Company") appointed Eric M. Williams (age 46) as Executive Vice President, Chief Financial Officer of the Company.
Mr. Williams succeeds Robert L. Lane, who will depart the company on June 30, 2024.
Mr. Rohan Hazelton, age 50, was appointed to serve as a director, filling the vacancy arising from Mr. Mladosich’s resignation, and as the Company’s new President, Chief Executive Officer, and interim Chief Financial Officer.
Mr. Koy D. Diepholz resigned his position as President, Chief Executive Officer, and interim Chief Financial Officer of the Company.
On June 6, 2024, L. Kian Granmayeh informed Carriage Services, Inc. (the “Company”) that he would resign from his position as Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer) of the Company effective July 1, 2024
the Company’s Board appointed Kathryn Shanley as the Company’s interim Principal Financial Officer, effective June 6, 2024
On June 5, 2024, the Boards of Directors of the Company and the Bank appointed Mr. Steven R. Larochelle to serve as the Chief Executive Officer of both the Company and the Bank, effective immediately.
On June 5, 2024, Mr. John P. Clancy, Jr., a director and the Chief Executive Officer of Enterprise Bancorp, Inc. (the “Company”) and its wholly owned subsidiary, Enterprise Bank & Trust Company (the “Bank”), notified the Boards of Directors of the Company and the Bank of his decision to retire from the Boards of Directors and as Chief Executive Officer of the Company and the Bank and transition to an executive advisor role.
On June 5, 2024, the Company appointed Nicholas M. Marcello as its Interim Chief Financial Officer, replacing John L. Villano in that position.
On June 5, 2024, the Company appointed Nicholas M. Marcello as its Interim Chief Financial Officer, replacing John L. Villano in that position.
Austin Harbour was appointed as the Company’s Chief Financial Officer effective June 17, 2024
Mr. Turner will resign as the Chief Financial Officer of the Company effective June 17, 2024
On June 6, 2024, the Board of Directors (the “Board”) of Semtech Corporation (“Semtech” or the “Company”) terminated Paul H. Pickle as President and Chief Executive Officer of the Company, without cause.
Hong Q. Hou, age 60, who has served as director of the Company since July 2023, will serve as President and Chief Executive Officer, effective as of June 6, 2024.
appointed Catherine J. Boggs to serve as Interim President and Chief Executive Officer effective May 22, 2024.
On June 5, 2024, Alphabet Inc. (“Alphabet”) announced the appointment of Anat Ashkenazi as the new Chief Financial Officer and Senior Vice President of Alphabet and Google LLC, effective July 31, 2024.
On June 3, 2024, the board of directors (the “Board”) of Fate Therapeutics, Inc. (the “Company”) appointed J. Scott Wolchko, the Company’s President and Chief Executive Officer, to succeed Edward J. Dulac III as the Company’s Chief Financial Officer and also serve as the Company’s principal financial and accounting officer, effective immediately after Mr. Dulac’s resignation.
Mr. Dulac provided notice of his resignation from his position as the Company’s Chief Financial Officer on May 30, 2024, which resignation shall be effective as of June 14, 2024.
On June 6, 2024, Masateru Higashida and Kevin J. Conner resigned from the board of directors of the Company (the “Board”) and any committee of the Board of which they were a member . Mr. Higashida also resigned from his positions of Chairman of the Board, Chief Executive Officer, Secretary, and Treasurer.
Further, effective on June 6, 2024, Ms. Wang and Randell Weaver, the existing Chief Financial Officer, Chief Operating Officer, and President of the Company, were both appointed to the Company as Co-Chief Executive Officers to fill the vacancy created by Mr. Higashida’s resignation. Mr. Weaver will also serve as Secretary and Treasurer to fill the vacancies created by Mr. Higashida’s resignation.
Also on June 6, 2024, Jianshuang Wang and Yanli Hou were appointed to the Board as directors to fill the vacancies created by Mr. Higashida’s and Mr. Conner’s resignations. It has not yet been determined on which committees of the Board Ms. Wang or Ms. Hou will serve, however, Ms. Wang will serve as the Chairman of the Board.
Effective June 6, 2024, the Board appointed Mr. Li as the Chief Executive Officer of the Company.
On June 3, 2024, Mr. Yumin Lin tendered his resignation as a member of the board of directors (the “Board”) and Chief Executive Officer of Fortune Valley Treasures, Inc. (the “Company”) due to personal reasons.
In connection with Mr. Ohri’s termination, on June 3, 2024, the Company has appointed Alan L. Urban as the Company’s Chief Financial Officer.
On June 3, 2024, Manu Ohri’s employment as Chief Financial Officer at GT Biopharma, Inc. (the “Company”) was terminated.
On the Closing Date, Mr. Thomas DeNunzio was appointed as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, Treasurer, and Director.
On the Closing Date, June 5, 2024, Mr. James Xilas resigned as the Company’s Chief Executive Officer, Chief Financial Officer, President, Secretary, and Treasurer.
the Board of Directors of the Company (the “Board”) appointed David F. Melbourne as Chief Executive Officer of the Company, effective June 7, 2024
Sylvia A. Wulf, who provided notice of her retirement from her role as Chief Executive Officer on June 6, 2024, effective June 7, 2024
On June 6, 2024, C.H. Robinson Worldwide, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed Damon Lee as Chief Financial Officer (“CFO”), effective the day after the Company files its Quarterly Report on Form 10-Q for the quarter ending June 30, 2024.
Coherent Corp. (the “Company”) made awards of restricted stock units (“RSU”) and performance stock units (“PSUs”) to its new Chief Executive Officer, James R. Anderson, effective on his start date, June 3, 2024.
Khairul Azmi Bin Ismaon Chairman, Chief Executive Officer and Director
Dr. Ulf Henning Richter Chief Financial Officer
On May 31, 2024, Justin H. Edenfield resigned as Principal Financial and Accounting Officer; Secretary of HG Holdings, Inc. (the “Company”).
In connection with Mr. Edenfield’s resignation, the board of directors of the Company (the “Board”) has elected Anna Lieb to serve as Principal Financial and Accounting Officer; Secretary of the Company effective as of May 31, 2024.
On June 2, 2024, Matthew L. Hoffman resigned as the Chief Financial Officer, Chief Operating Officer and from any and all other positions held by him at The Coretec Group Inc. (the “Company”), effective immediately.
Effective as of June 4, 2024, the Board of Directors (the “Board”) of LuxUrban Hotels Inc. (the “Company”) appointed Michael James as Chief Financial Officer of the Company.
Birger K. Steen, the Company’s Chief Executive Officer (“CEO”), would be leaving the Company effective as of June 6, 2024, and that he will not stand for re-election as a member of the Company’s Board of Directors
Additionally, in connection with Mr. Jensen’s appointment as the Company’s CEO, effective June 6, 2024, Mr. Jensen resigned from his current position as Executive Chair of the Board, and the Board has appointed Daniel Barcelo as Chair of the Board, effective on the same day.
Douglas M. Worman, Executive Vice President and Global Head of Underwriting of the Registrant, was appointed President and Chief Executive Officer of the Registrant, effective January 1, 2025.
Anat Ashkenazi resigned as Executive Vice President and Chief Financial Officer of the Company to pursue another career opportunity outside of the pharmaceutical industry.
Scott Carter, a member of the Board of Directors of the Company (the “Board”), was appointed as Interim Chief Executive Officer of the Company, effective as of June 1, 2024.
Sterling Check Corp. (the “Company”) has appointed Richard Dziadzio as Executive Vice President, Interim Chief Financial Officer, effective June 5, 2024.
On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.
appointed John Bostjancic, age 53, to serve as Chief Financial Officer of the Company, effective June 5, 2024.
As previously disclosed, on April 25, 2024, the board of directors (the “Board”) of Akari Therapeutics, Plc (the “Company”) appointed Samir R. Patel, M.D., a member of the Board, as Interim President and Chief Executive Officer, effective May 1, 2024, to serve in such capacities until such time as determined by the Board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.